Logo image of BLMN

BLOOMIN' BRANDS INC (BLMN) Stock Fundamental Analysis

NASDAQ:BLMN - Nasdaq - US0942351083 - Common Stock - Currency: USD

12.62  +0.06 (+0.48%)

After market: 12.62 0 (0%)

Fundamental Rating

4

Overall BLMN gets a fundamental rating of 4 out of 10. We evaluated BLMN against 134 industry peers in the Hotels, Restaurants & Leisure industry. While BLMN is still in line with the averages on profitability rating, there are concerns on its financial health. BLMN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BLMN had positive earnings in the past year.
In the past year BLMN had a positive cash flow from operations.
Of the past 5 years BLMN 4 years were profitable.
Each year in the past 5 years BLMN had a positive operating cash flow.
BLMN Yearly Net Income VS EBIT VS OCF VS FCFBLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

1.2 Ratios

BLMN has a Return On Assets of -0.15%. This is in the lower half of the industry: BLMN underperforms 64.12% of its industry peers.
BLMN has a Return On Equity (-2.18%) which is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 8.45%, BLMN is doing good in the industry, outperforming 67.94% of the companies in the same industry.
BLMN had an Average Return On Invested Capital over the past 3 years of 12.76%. This is above the industry average of 10.59%.
The last Return On Invested Capital (8.45%) for BLMN is well below the 3 year average (12.76%), which needs to be investigated, but indicates that BLMN had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.15%
ROE -2.18%
ROIC 8.45%
ROA(3y)5.61%
ROA(5y)3.13%
ROE(3y)65.87%
ROE(5y)-736.36%
ROIC(3y)12.76%
ROIC(5y)N/A
BLMN Yearly ROA, ROE, ROICBLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K

1.3 Margins

BLMN's Profit Margin has improved in the last couple of years.
BLMN has a Operating Margin of 5.82%. This is in the lower half of the industry: BLMN underperforms 60.31% of its industry peers.
In the last couple of years the Operating Margin of BLMN has grown nicely.
Looking at the Gross Margin, with a value of 70.30%, BLMN belongs to the top of the industry, outperforming 84.73% of the companies in the same industry.
BLMN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.82%
PM (TTM) N/A
GM 70.3%
OM growth 3YN/A
OM growth 5Y11.58%
PM growth 3YN/A
PM growth 5Y15.33%
GM growth 3Y0.22%
GM growth 5Y0.35%
BLMN Yearly Profit, Operating, Gross MarginsBLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BLMN is creating some value.
Compared to 1 year ago, BLMN has less shares outstanding
Compared to 5 years ago, BLMN has less shares outstanding
Compared to 1 year ago, BLMN has an improved debt to assets ratio.
BLMN Yearly Shares OutstandingBLMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
BLMN Yearly Total Debt VS Total AssetsBLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.23, we must say that BLMN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BLMN (1.23) is comparable to the rest of the industry.
BLMN has a Debt/Equity ratio of 4.54. This is a high value indicating a heavy dependency on external financing.
BLMN's Debt to Equity ratio of 4.54 is on the low side compared to the rest of the industry. BLMN is outperformed by 61.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.54
Debt/FCF N/A
Altman-Z 1.23
ROIC/WACC1.01
WACC8.39%
BLMN Yearly LT Debt VS Equity VS FCFBLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.31 indicates that BLMN may have some problems paying its short term obligations.
BLMN's Current ratio of 0.31 is on the low side compared to the rest of the industry. BLMN is outperformed by 89.31% of its industry peers.
BLMN has a Quick Ratio of 0.31. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
BLMN has a Quick ratio of 0.22. This is amonst the worse of the industry: BLMN underperforms 94.66% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.22
BLMN Yearly Current Assets VS Current LiabilitesBLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

1

3. Growth

3.1 Past

The earnings per share for BLMN have decreased strongly by -23.59% in the last year.
Measured over the past years, BLMN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.33% on average per year.
Looking at the last year, BLMN shows a decrease in Revenue. The Revenue has decreased by -0.55% in the last year.
Measured over the past years, BLMN shows a small growth in Revenue. The Revenue has been growing by 2.51% on average per year.
EPS 1Y (TTM)-23.59%
EPS 3YN/A
EPS 5Y14.33%
EPS Q2Q%-52.27%
Revenue 1Y (TTM)-0.55%
Revenue growth 3Y13.79%
Revenue growth 5Y2.51%
Sales Q2Q%-3.8%

3.2 Future

The Earnings Per Share is expected to decrease by -6.81% on average over the next years.
BLMN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.80% yearly.
EPS Next Y-37.37%
EPS Next 2Y-20.82%
EPS Next 3Y-10.49%
EPS Next 5Y-6.81%
Revenue Next Year-5.06%
Revenue Next 2Y-4.73%
Revenue Next 3Y-2.65%
Revenue Next 5Y-1.8%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLMN Yearly Revenue VS EstimatesBLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BLMN Yearly EPS VS EstimatesBLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.82, the valuation of BLMN can be described as very cheap.
BLMN's Price/Earnings ratio is rather cheap when compared to the industry. BLMN is cheaper than 97.71% of the companies in the same industry.
When comparing the Price/Earnings ratio of BLMN to the average of the S&P500 Index (28.47), we can say BLMN is valued rather cheaply.
With a Price/Forward Earnings ratio of 6.92, the valuation of BLMN can be described as very cheap.
98.47% of the companies in the same industry are more expensive than BLMN, based on the Price/Forward Earnings ratio.
BLMN is valuated cheaply when we compare the Price/Forward Earnings ratio to 92.74, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.82
Fwd PE 6.92
BLMN Price Earnings VS Forward Price EarningsBLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

96.18% of the companies in the same industry are more expensive than BLMN, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.51
BLMN Per share dataBLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

BLMN has a very decent profitability rating, which may justify a higher PE ratio.
BLMN's earnings are expected to decrease with -10.49% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.41
EPS Next 2Y-20.82%
EPS Next 3Y-10.49%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.45%, BLMN is a good candidate for dividend investing.
BLMN's Dividend Yield is rather good when compared to the industry average which is at 3.09. BLMN pays more dividend than 97.71% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.28, BLMN pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.45%

5.2 History

On average, the dividend of BLMN grows each year by 21.41%, which is quite nice.
BLMN has been paying a dividend for over 5 years, so it has already some track record.
BLMN has decreased its dividend in the last 3 years.
Dividend Growth(5Y)21.41%
Div Incr Years1
Div Non Decr Years2
BLMN Yearly Dividends per shareBLMN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

BLMN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1570.91%
EPS Next 2Y-20.82%
EPS Next 3Y-10.49%
BLMN Yearly Income VS Free CF VS DividendBLMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

BLOOMIN' BRANDS INC

NASDAQ:BLMN (2/4/2025, 8:00:01 PM)

After market: 12.62 0 (0%)

12.62

+0.06 (+0.48%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)02-13 2025-02-13/amc
Inst Owners104.73%
Inst Owner Change-4.67%
Ins Owners1.45%
Ins Owner Change0.39%
Market Cap1.07B
Analysts69.47
Price Target15.73 (24.64%)
Short Float %12.87%
Short Ratio6.07
Dividend
Industry RankSector Rank
Dividend Yield 7.45%
Yearly Dividend0.96
Dividend Growth(5Y)21.41%
DP-1570.91%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.54%
Min EPS beat(2)-13.76%
Max EPS beat(2)0.68%
EPS beat(4)2
Avg EPS beat(4)-3.57%
Min EPS beat(4)-13.76%
Max EPS beat(4)6.55%
EPS beat(8)6
Avg EPS beat(8)1.95%
EPS beat(12)10
Avg EPS beat(12)3.63%
EPS beat(16)13
Avg EPS beat(16)27.59%
Revenue beat(2)0
Avg Revenue beat(2)-2.45%
Min Revenue beat(2)-2.62%
Max Revenue beat(2)-2.28%
Revenue beat(4)0
Avg Revenue beat(4)-2.32%
Min Revenue beat(4)-2.62%
Max Revenue beat(4)-2.1%
Revenue beat(8)1
Avg Revenue beat(8)-2.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.77%
Revenue beat(16)4
Avg Revenue beat(16)-1.89%
PT rev (1m)-9.72%
PT rev (3m)-25.29%
EPS NQ rev (1m)-2.78%
EPS NQ rev (3m)-52.27%
EPS NY rev (1m)-0.43%
EPS NY rev (3m)-14.25%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)-5.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.68%
Valuation
Industry RankSector Rank
PE 5.82
Fwd PE 6.92
P/S 0.24
P/FCF N/A
P/OCF 4.01
P/B 4.42
P/tB N/A
EV/EBITDA 4.51
EPS(TTM)2.17
EY17.19%
EPS(NY)1.82
Fwd EY14.46%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)3.15
OCFY24.96%
SpS53.6
BVpS2.85
TBVpS-5.47
PEG (NY)N/A
PEG (5Y)0.41
Profitability
Industry RankSector Rank
ROA -0.15%
ROE -2.18%
ROCE 10.23%
ROIC 8.45%
ROICexc 8.73%
ROICexgc 12.16%
OM 5.82%
PM (TTM) N/A
GM 70.3%
FCFM N/A
ROA(3y)5.61%
ROA(5y)3.13%
ROE(3y)65.87%
ROE(5y)-736.36%
ROIC(3y)12.76%
ROIC(5y)N/A
ROICexc(3y)13.29%
ROICexc(5y)N/A
ROICexgc(3y)19.82%
ROICexgc(5y)N/A
ROCE(3y)15.46%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y0.04%
ROICexc growth 3YN/A
ROICexc growth 5Y6.3%
OM growth 3YN/A
OM growth 5Y11.58%
PM growth 3YN/A
PM growth 5Y15.33%
GM growth 3Y0.22%
GM growth 5Y0.35%
F-Score5
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 4.54
Debt/FCF N/A
Debt/EBITDA 2.38
Cap/Depr 149.19%
Cap/Sales 6.51%
Interest Coverage 4.24
Cash Conversion 57.74%
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.22
Altman-Z 1.23
F-Score5
WACC8.39%
ROIC/WACC1.01
Cap/Depr(3y)124.77%
Cap/Depr(5y)101.05%
Cap/Sales(3y)4.96%
Cap/Sales(5y)4.31%
Profit Quality(3y)127.3%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.59%
EPS 3YN/A
EPS 5Y14.33%
EPS Q2Q%-52.27%
EPS Next Y-37.37%
EPS Next 2Y-20.82%
EPS Next 3Y-10.49%
EPS Next 5Y-6.81%
Revenue 1Y (TTM)-0.55%
Revenue growth 3Y13.79%
Revenue growth 5Y2.51%
Sales Q2Q%-3.8%
Revenue Next Year-5.06%
Revenue Next 2Y-4.73%
Revenue Next 3Y-2.65%
Revenue Next 5Y-1.8%
EBIT growth 1Y-26.4%
EBIT growth 3YN/A
EBIT growth 5Y14.38%
EBIT Next Year22.81%
EBIT Next 3Y6.78%
EBIT Next 5Y5.14%
FCF growth 1Y-113.24%
FCF growth 3Y59.81%
FCF growth 5Y21.11%
OCF growth 1Y-31.64%
OCF growth 3Y56.54%
OCF growth 5Y13.07%